CYTO(Delisted)
AltamiraยทNASDAQ
--
--(--)
CYTO Profile
Altamira Therapeutics Ltd.
A developer of RNA therapeutics for allergy and viral infections, and inner ear disorders
Clarendon House, 2 Church Street, Hamilton HM11, Bermuda
--
Altamira Therapeutics Ltd. was established in 1998. The company's goal is to become a leading biomedical company focused on developing and commercializing RNA delivery technologies. The company believes that the use of RNA therapy, whether siRNA, mRNA or other types to control the expression of disease-associated genes, has great prospects. By utilizing the targets of small molecules and proteins that are "ineffective" in other aspects, it is expected to open up a new way of RNA therapy for the treatment of intractable diseases.
